Analysis of Causes and Results of Fetal Growth in Utero Caused by Genetic Factors Detected by Ultrasound.


Journal

Contrast media & molecular imaging
ISSN: 1555-4317
Titre abrégé: Contrast Media Mol Imaging
Pays: England
ID NLM: 101286760

Informations de publication

Date de publication:
2022
Historique:
received: 17 07 2022
revised: 06 08 2022
accepted: 16 08 2022
entrez: 15 9 2022
pubmed: 16 9 2022
medline: 17 9 2022
Statut: epublish

Résumé

In order to investigate the value of the ultrasonic monitoring of maternal and fetal vascular parameters, serum vitamin D, and placental growth factor (PLGF) in predicting fetal growth restriction (FGR), a method of ultrasonic detection of genetic factors causing fetal growth in utero was proposed. 125 pregnant women with FGR diagnosed in our hospital from June 2018 to June 2021 (the FGR group) and 125 pregnant women with a normal prenatal examination (the control group) were collected retrospectively. The systolic/diastolic blood flow ratio (S/D), pulsatile index (PI), and resistance index (RI) of the fetal umbilical artery (UA), middle cerebral artery (MCA), and maternal uterine artery (UtA) were monitored by ultrasound at 20 to 24 weeks of gestation, and the levels of serum vitamin D and PLGF were detected. The receiver operating characteristic curve (ROC curve) was used to evaluate the predictive value of FGR. The results showed that the S/D, PI, and RI of UA in the FGR group were higher than those in the control group, the areas under the curve (AUC) were 0.866, 0.817, and 0.849, and the sensitivity and specificity were (72.8%, 91.2%), (50.4%, 100%), and (72.8%, 91.2%), respectively. The S/D, PI, and RI of MCA were lower than those of the control group. The AUC was 0.882, 0.869, and 0.834, respectively; the sensitivity and specificity were (92.0%, 74.4%), (88.8%, 81.6%), and (90.4%, 72%), respectively. The S/D, PI, and RI of UtA were higher than those of the control group; the AUC was 0.768, 0.729, and 0.732; the sensitivity and specificity were (91.2%, 52%), (48%, 90.4%), and (48.8%, 90.4%), respectively. The serum levels of vitamin D and PLGF were lower than those of the control group (AUC 0.784 and 0.807), and the sensitivity and specificity were (54.4%, 91.2%) and (99.2%, 52%), respectively. It was concluded that the ultrasound monitoring of UA, MCA, and UtA in pregnant women in the middle of pregnancy and detection of serum vitamin D and PLGF levels had a certain predictive value for FGR. Moreover, the comprehensive evaluation could reduce the occurrence of FGR in high-risk pregnant women.

Identifiants

pubmed: 36105440
doi: 10.1155/2022/3703132
pmc: PMC9452974
doi:

Substances chimiques

Vitamin D 1406-16-2
Placenta Growth Factor 144589-93-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't Retracted Publication

Langues

eng

Sous-ensembles de citation

IM

Pagination

3703132

Commentaires et corrections

Type : RetractionIn

Informations de copyright

Copyright © 2022 Mei Yu et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Trends Mol Med. 2021 Aug;27(8):743-752
pubmed: 34147360
Placenta. 2020 Jul;96:10-18
pubmed: 32421528
J Healthc Eng. 2020 Jan 9;2020:7156408
pubmed: 32377330
Placenta. 2021 Nov;115:87-96
pubmed: 34583270
Clin Imaging. 2020 Jun;62:57-62
pubmed: 32066034
Br J Nutr. 2020 Aug 28;124(4):432-439
pubmed: 32213215
RSC Adv. 2021 Jun 11;11(34):20865-20873
pubmed: 35479388
Physiology (Bethesda). 2021 Jul 1;36(4):256-266
pubmed: 34159809
J Radiol Prot. 2022 Jan 17;42(1):
pubmed: 34985415
Sensors (Basel). 2021 Jan 27;21(3):
pubmed: 33513784
Placenta. 2022 May;122:1-8
pubmed: 35378370
Placenta. 2020 Feb;91:24-30
pubmed: 32174303
Nanotechnol Rev. 2020;9(1):1217-1226
pubmed: 34012762
RSC Adv. 2021 Nov 10;11(57):36199-36207
pubmed: 35492760
Langmuir. 2020 Mar 24;36(11):2886-2892
pubmed: 32118445
J Control Release. 2021 Jun 10;334:96-105
pubmed: 33811984
J Perinat Med. 2020 Apr 2;:
pubmed: 32242833

Auteurs

Mei Yu (M)

Prenatal Diagnosis Center, The Fourth Hospital of Shijiazhuang (The Obstetrics and Gynecology Hospital of Hebei Medical University), Shijiazhuang, Hebei, China.

Ying Liu (Y)

Obstetrical Department VIII, The Fourth Hospital of Shijiazhaung (The Obstetrics and Gynecology Hospital of Hebei Medical University), Shijiazhuang, Hebei, China.

Liya Wang (L)

Neonatal Surgery, The Fourth Hospital of Shijiazhuang (The Obstetrics and Gynecology Hospital of Hebei Medical University), Shijiazhuang, Hebei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH